Quality of life in head and neck cancer patients

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35

Kristin Bjordal*, Eva Hammerlid, Marianne Ahlner-Elmqvist, Alexander De Graeff, Morten Boysen, Jan F. Evensen, Anders Biörklund, J. Rob J. De Leeuw, Peter M. Fayers, Magnus Jannert, Thomas Westin, Stein Kaasa

*Corresponding author for this work

Research output: Contribution to journalArticle

487 Citations (Scopus)

Abstract

Purpose: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)H and N35, a questionnaire designed to assess the quality of life of head and neck (H and N) cancer patients in conjunction with the general cancer- specific EORTC QLQ-C30. Patients and Methods: Questionnaires were given to 500 H and N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. Results: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H and N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. Conclusion: The QLQ-H and N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H and N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.

Original languageEnglish
Pages (from-to)1008-1019
Number of pages12
JournalJournal of Clinical Oncology
Volume17
Issue number3
DOIs
Publication statusPublished - 1 Mar 1999

Fingerprint

Head and Neck Neoplasms
Quality of Life
Organizations
Research
Neoplasms
Therapeutics
Norway
Sweden
Surveys and Questionnaires
Laryngeal Neoplasms
Glandular and Epithelial Neoplasms
Sexuality
Deglutition
Nose
Reproducibility of Results
Netherlands
Radiotherapy
Eating
Prospective Studies
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Quality of life in head and neck cancer patients : Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35. / Bjordal, Kristin; Hammerlid, Eva; Ahlner-Elmqvist, Marianne; De Graeff, Alexander; Boysen, Morten; Evensen, Jan F.; Biörklund, Anders; De Leeuw, J. Rob J.; Fayers, Peter M.; Jannert, Magnus; Westin, Thomas; Kaasa, Stein.

In: Journal of Clinical Oncology, Vol. 17, No. 3, 01.03.1999, p. 1008-1019.

Research output: Contribution to journalArticle

Bjordal, K, Hammerlid, E, Ahlner-Elmqvist, M, De Graeff, A, Boysen, M, Evensen, JF, Biörklund, A, De Leeuw, JRJ, Fayers, PM, Jannert, M, Westin, T & Kaasa, S 1999, 'Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35', Journal of Clinical Oncology, vol. 17, no. 3, pp. 1008-1019. https://doi.org/10.1200/JCO.1999.17.3.1008
Bjordal, Kristin ; Hammerlid, Eva ; Ahlner-Elmqvist, Marianne ; De Graeff, Alexander ; Boysen, Morten ; Evensen, Jan F. ; Biörklund, Anders ; De Leeuw, J. Rob J. ; Fayers, Peter M. ; Jannert, Magnus ; Westin, Thomas ; Kaasa, Stein. / Quality of life in head and neck cancer patients : Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35. In: Journal of Clinical Oncology. 1999 ; Vol. 17, No. 3. pp. 1008-1019.
@article{5fa5d77c3ed34bc59db1e744f5557423,
title = "Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35",
abstract = "Purpose: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)H and N35, a questionnaire designed to assess the quality of life of head and neck (H and N) cancer patients in conjunction with the general cancer- specific EORTC QLQ-C30. Patients and Methods: Questionnaires were given to 500 H and N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. Results: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H and N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. Conclusion: The QLQ-H and N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H and N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.",
author = "Kristin Bjordal and Eva Hammerlid and Marianne Ahlner-Elmqvist and {De Graeff}, Alexander and Morten Boysen and Evensen, {Jan F.} and Anders Bi{\"o}rklund and {De Leeuw}, {J. Rob J.} and Fayers, {Peter M.} and Magnus Jannert and Thomas Westin and Stein Kaasa",
year = "1999",
month = "3",
day = "1",
doi = "10.1200/JCO.1999.17.3.1008",
language = "English",
volume = "17",
pages = "1008--1019",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",

}

TY - JOUR

T1 - Quality of life in head and neck cancer patients

T2 - Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35

AU - Bjordal, Kristin

AU - Hammerlid, Eva

AU - Ahlner-Elmqvist, Marianne

AU - De Graeff, Alexander

AU - Boysen, Morten

AU - Evensen, Jan F.

AU - Biörklund, Anders

AU - De Leeuw, J. Rob J.

AU - Fayers, Peter M.

AU - Jannert, Magnus

AU - Westin, Thomas

AU - Kaasa, Stein

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Purpose: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)H and N35, a questionnaire designed to assess the quality of life of head and neck (H and N) cancer patients in conjunction with the general cancer- specific EORTC QLQ-C30. Patients and Methods: Questionnaires were given to 500 H and N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. Results: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H and N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. Conclusion: The QLQ-H and N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H and N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.

AB - Purpose: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)H and N35, a questionnaire designed to assess the quality of life of head and neck (H and N) cancer patients in conjunction with the general cancer- specific EORTC QLQ-C30. Patients and Methods: Questionnaires were given to 500 H and N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. Results: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H and N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. Conclusion: The QLQ-H and N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H and N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0032980277&partnerID=8YFLogxK

U2 - 10.1200/JCO.1999.17.3.1008

DO - 10.1200/JCO.1999.17.3.1008

M3 - Article

VL - 17

SP - 1008

EP - 1019

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -